Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermaPro versus saline for diabetic foot ulcers
2012-005841-19Phase 3Completed
- Sponsor
- DermaTools Biotech
- Start
- Jan 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of DermaPro in diabetic foot ulcer (DFU) (2 arms), sponsored by DermaTools Biotech. Primary endpoint: Proportion of patients with wound closure and sustained wound closure. Started Jan 2013; status: completed.
02
Drugs
DermaPro
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2012-005841-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005841-19.